Business Description
Chordate Medical Holding AB
ISIN : SE0022726139
Total Employee Number:
3Description
Chordate Medical Holding AB is a medical technology company that has developed patented and CE-marked a new nerve-modulating treatment technology for chronic nasal congestion and chronic migraine. The company sells its products in Selected European markets, Israel, and Saudi Arabia. The company's product range is based on the CE-marked treatment units Chordate System S100 and S120 for rhinitis and S220 for migraine, registered for the indications of preventive treatment of chronic migraine and chronic rhinitis and use on patients. The company sells its product system, including treatments, through distributors to clinics and hospitals in its primary markets.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.77 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -4.21 | |||||
Beneish M-Score | -3.73 | |||||
WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 376.5 | |||||
3-Year EBITDA Growth Rate | -475.7 | |||||
3-Year EPS without NRI Growth Rate | 27.1 | |||||
3-Year FCF Growth Rate | -479.2 | |||||
3-Year Book Growth Rate | 217.3 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 17.64 | |||||
9-Day RSI | 22.1 | |||||
14-Day RSI | 26.79 | |||||
3-1 Month Momentum % | -30.68 | |||||
6-1 Month Momentum % | -88.79 | |||||
12-1 Month Momentum % | -91 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.97 | |||||
Quick Ratio | 1.54 | |||||
Cash Ratio | 1.02 | |||||
Days Inventory | 3469.28 | |||||
Days Sales Outstanding | 103.44 | |||||
Days Payable | 3641.71 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 80.5 | |||||
Shareholder Yield % | -4050.69 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 81.37 | |||||
Operating Margin % | -2539.17 | |||||
Net Margin % | -2533.74 | |||||
EBITDA Margin % | -2353.78 | |||||
FCF Margin % | -2591.01 | |||||
OCF Margin % | -2480.9 | |||||
ROE % | -159.75 | |||||
ROA % | -117.69 | |||||
ROIC % | -181.03 | |||||
3-Year ROIIC % | -1033.33 | |||||
ROC (Joel Greenblatt) % | -1255.3 | |||||
ROCE % | -160.09 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 0.28 | |||||
PB Ratio | 0.03 | |||||
Price-to-Tangible-Book | 0.05 | |||||
EV-to-EBIT | 0.15 | |||||
EV-to-EBITDA | 0.16 | |||||
EV-to-Revenue | -3.84 | |||||
EV-to-FCF | 0.15 | |||||
Price-to-GF-Value | 0.01 | |||||
| Price-to-Net-Current-Asset-Value | 0.1 | |||||
Earnings Yield (Greenblatt) % | 666.67 | |||||
FCF Yield % | -5965.28 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Chordate Medical Holding AB Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 0.089 | ||
| EPS (TTM) (€) | -1.66 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | 0.48 | ||
| 3-Year Sortino Ratio | 6.73 | ||
| Volatility % | 130.21 | ||
| 14-Day RSI | 26.79 | ||
| 14-Day ATR (€) | 0.004549 | ||
| 20-Day SMA (€) | 0.02404 | ||
| 12-1 Month Momentum % | -91 | ||
| 52-Week Range (€) | 0.001 - 1.1 | ||
| Shares Outstanding (Mil) | 2.7 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Chordate Medical Holding AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Chordate Medical Holding AB Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-11-20 | In 140 days | ||
| Third quarter earnings results for 2026 | 2026-11-20 | In 140 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-28 | In 56 days | ||
| Second quarter earnings results for 2026 | 2026-08-28 | In 56 days | ||
| First quarter earnings conference call for 2026 | 2026-05-22 | 0.00 (+0.00%) | ||
| First quarter earnings results for 2026 | 2026-05-22 | 0.00 (+0.00%) | ||
| General meeting for 2025 | 2026-05-21 15:00 | 0.00 (+0.00%) | ||
| Annual report for 2025 | 2026-04-10 | 0.00 (+0.00%) | ||
| Fourth quarter earnings conference call for 2025 | 2026-03-27 | 0.00 (+0.00%) | ||
| Fourth quarter earnings results for 2025 | 2026-03-27 | 0.00 (+0.00%) |
Show
Entries
Chordate Medical Holding AB Frequently Asked Questions
What is Chordate Medical Holding AB(FRA:K1Z)'s stock price today?
The current price of FRA:K1Z is €0.00. The 52 week high of FRA:K1Z is €1.10 and 52 week low is €0.00.
When is next earnings date of Chordate Medical Holding AB(FRA:K1Z)?
The next earnings date of Chordate Medical Holding AB(FRA:K1Z) is 2026-08-28 Est..
Does Chordate Medical Holding AB(FRA:K1Z) pay dividends? If so, how much?
Chordate Medical Holding AB(FRA:K1Z) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Chordate Medical Holding AB
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers